Key result
Data demonstrating that inferior vena cava filters reduce thrombosis-related morbidity or mortality in patients with venous thromboembolism are lacking.
Why the study?
While use of inferior vena cava filters has increased, data demonstrating that they reduce thrombosis-related morbidity or mortality are lacking.
While anticoagulation remains the standard for treatment of acute deep vein thrombosis (DVT) and pulmonary embolism (PE), use of inferior vena cava filters (IVCFs) has increased in recent decades [1,2]. IVCFs were designed to trap thrombi originating in lower-extremity veins to prevent the development of clinically significant PE [2]. However, data demonstrating that IVCFs reduce thrombosis-related morbidity or mortality are lacking [2,3].
No takes yet. Share an insight, caveat, or question.
Ladak et al. (2024) studied Venous thromboembolism (acute deep vein thrombosis and pulmonary embolism). Inferior vena cava filters was evaluated. Data demonstrating that inferior vena cava filters reduce thrombosis-related morbidity or mortality in patients with venous thromboembolism are lacking.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: